The GMP Insider

Tushar Arora
  • 0.0 (0)
  • Life Sciences

GMP Insider is your go-to podcast for practical insights into pharmaceutical quality, Good Manufacturing Practices (GMP), and regulatory compliance. Designed for quality professionals, manufacturing teams, and pharma leaders, this show breaks down complex regulations into clear, real-world guidance. Each episode explores topics like audits, CAPA, data integrity, quality systems, validation, and global regulatory expectations — all with a focus on protecting patients and building strong quality cultures. Whether you work in Quality Assurance, Quality Control, Manufacturing, or Regulatory Affairs, GMP Insider helps you stay compliant, confident, and ahead in an ever-evolving pharmaceutical industry. New episodes deliver:• GMP best practices• Audit readiness strategies• Real compliance case studies• Industry trends and updates• Expert tips from quality professionals From batch to patient — quality is everything.

  1. 2d ago

    Quality Debt: The Hidden Liability Inside Pharmaceutical Quality Systems

    Every shortcut, deferred CAPA, and "we'll fix it later" is a loan — and quality debt charges interest. Repeat deviations, findings, and warning letters are just the payments coming due. • What quality debt is and how it silently accumulates • The interest payments: repeat deviations and FDA findings • Paying it down without stopping the line • Preventing new debt while clearing the old New episodes every Monday and Wednesday — follow The GMP Insider so you never miss one. Connect with Tushar Arora on LinkedIn: https://www.linkedin.com/in/tushar-a-926382161 Watch on YouTube: https://www.youtube.com/@TheGMPInsider Produced with AI assistance.

  2. 4d ago

    The Hidden Cost of Poor Quality: The Business Impact Beyond Recalls

    Recalls make the headlines. But the real cost of poor quality never makes the press release — it hides in rework, investigations, remediation, and the launches that never happen. • The costs nobody puts on the recall announcement • Rework, investigations, and remediation: the real math • How poor quality taxes every future product launch • Making the business case for quality investment New episodes every Monday and Wednesday — follow The GMP Insider so you never miss one. Connect with Tushar Arora on LinkedIn: https://www.linkedin.com/in/tushar-a-926382161 Watch on YouTube: https://www.youtube.com/@TheGMPInsider Produced with AI assistance.

  3. Sep 30

    Why CAPA Doesn't Fix Culture: Symptoms vs Systems

    Your CAPA system can be perfect on paper and still change nothing — because CAPAs fix symptoms, and culture is the system underneath. • Why brilliant CAPAs die in broken cultures • Symptoms vs systems: knowing which one you're treating • What culture change actually requires from QA leaders • Building a system where CAPAs stick New episodes every Monday and Wednesday — follow The GMP Insider so you never miss one. Connect with Tushar Arora on LinkedIn: https://www.linkedin.com/in/tushar-a-926382161 Watch on YouTube: https://www.youtube.com/@TheGMPInsider Produced with AI assistance.

  4. Sep 28

    Compliance vs Effectiveness: Is Your Quality System Healthy?

    Compliant doesn't mean effective. Effective doesn't mean sustainable. Most quality systems are only one of the three — and leadership can't tell which. • The three lenses every quality system needs • Why compliance alone is a fragile victory • Measuring effectiveness, not just activity • Building a system that lasts beyond the next inspection New episodes every Monday and Wednesday — follow The GMP Insider so you never miss one. Connect with Tushar Arora on LinkedIn: https://www.linkedin.com/in/tushar-a-926382161 Watch on YouTube: https://www.youtube.com/@TheGMPInsider Produced with AI assistance.

  5. Sep 23

    When a Green Dashboard Lies: Signals Your Metrics Miss

    Every metric green, every trend flat — and the system is rotting underneath. Dashboards don't lie on purpose. They lie by design. • Why green metrics create dangerous comfort • The quality signals dashboards systematically miss • What to measure when the numbers look fine • Leading beyond the dashboard New episodes every Monday and Wednesday — follow The GMP Insider so you never miss one. Connect with Tushar Arora on LinkedIn: https://www.linkedin.com/in/tushar-a-926382161 Watch on YouTube: https://www.youtube.com/@TheGMPInsider Produced with AI assistance.

  6. Sep 21

    When Quality Has to Say NO: Tough QA Decisions in Pharma

    Saying no in QA is easy on paper and brutal in practice. This episode is about the decision nobody wants to make — and why making it is the job. • Why "no" is a quality decision, not a career risk • How great QA leaders frame rejection so it actually lands • The difference between blocking progress and protecting patients • Sleeping well after the hardest call of your career New episodes every Monday and Wednesday — follow The GMP Insider so you never miss one. Connect with Tushar Arora on LinkedIn: https://www.linkedin.com/in/tushar-a-926382161 Watch on YouTube: https://www.youtube.com/@TheGMPInsider Produced with AI assistance.

  7. Sep 13

    AI Governance in Pharma: Ethics by Design for Quality Leaders

    AI governance in the pharmaceutical industry cannot begin after deployment. By that point, critical decisions about data, accountability, human oversight, transparency, risk, and system behavior have already been embedded into the technology. So the better question is: What if ethics were designed into AI from the beginning? In this episode of The GMP Insider, we explore the concept of Ethics by Design and why it could become a foundational pillar of responsible AI governance in pharmaceutical Quality. Discussion topics include: Why AI governance must begin during system design Patient safety considerations when AI makes mistakes Transparency and understanding AI outputs Designing meaningful human oversight Data integrity and AI governance Identifying potential bias and unintended outcomes Defining accountability when AI contributes to decisions Managing AI and model changes throughout the lifecycle The evolving role of QA in AI governance Why policies alone may not be sufficient for complex AI systems For GxP and other regulated environments, responsible AI requires more than a policy describing how technology should be used. Organizations need governance principles embedded into the design, validation, deployment, monitoring, and change management lifecycle. The objective shouldn't be to create another compliance checklist. It should be to build systems with appropriate ethical guardrails from the start. Because as AI becomes more complex, governance must become more intentional. Define accountability before deployment. Design for human oversight. Protect data integrity. Monitor continuously. Engineer trust from the beginning. The central question for pharmaceutical AI should not simply be: "Can we use this technology?" It should also be: "Can we govern it responsibly—and can we trust the way it was designed?" You cannot govern complexity effectively if ethics is treated as an afterthought. From batch to patient — quality is everything.

  8. Sep 13

    Big Pharma vs Small Pharma: Where Quality Culture Thrives

    What is it really like to work in Quality Assurance at a large pharmaceutical company compared with a smaller organization? The answer goes far beyond company size. In this episode of The GMP Insider, we explore how Big Pharma and Small Pharma can develop very different professional skills, experiences, and perspectives—and why Quality Culture often matters more than organizational scale. Big Pharma can provide mature systems, specialized expertise, global standards, established governance, and the opportunity to learn how to operate within complex organizations. Small Pharma can provide broader responsibilities, faster decision-making, greater visibility, cross-functional exposure, and opportunities to build Quality Systems from the ground up. Neither is inherently better. They simply develop different muscles. In this episode, we discuss: The advantages of working in Big Pharma The professional opportunities available in Small Pharma Managing complexity versus creating change How organizational size affects decision-making The importance of leadership and Quality Culture Why speaking up and challenging respectfully matter How both environments can accelerate a QA professional's career What truly defines an exceptional Quality organization The best Quality culture isn't necessarily found in the company with the largest budget or the most sophisticated systems. It's found where people are empowered to speak up, learn from failures, take ownership, support each other, and put patients first. Big Pharma can teach you how to manage complexity. Small Pharma can teach you how to create change. The strongest professionals learn from both. Company size may shape the system. Leadership and culture shape the experience. From batch to patient — quality is everything.

See All (69)

About

GMP Insider is your go-to podcast for practical insights into pharmaceutical quality, Good Manufacturing Practices (GMP), and regulatory compliance. Designed for quality professionals, manufacturing teams, and pharma leaders, this show breaks down complex regulations into clear, real-world guidance. Each episode explores topics like audits, CAPA, data integrity, quality systems, validation, and global regulatory expectations — all with a focus on protecting patients and building strong quality cultures. Whether you work in Quality Assurance, Quality Control, Manufacturing, or Regulatory Affairs, GMP Insider helps you stay compliant, confident, and ahead in an ever-evolving pharmaceutical industry. New episodes deliver:• GMP best practices• Audit readiness strategies• Real compliance case studies• Industry trends and updates• Expert tips from quality professionals From batch to patient — quality is everything.

Information

  • Creator
    Tushar Arora
  • Years Active
    2026
  • Episodes
    69
  • Rating
    Clean
  • Copyright
    © Copyright 2026 by Tushar Arora
  • Show Website
    The GMP Insider

You Might Also Like